Delaware Intellectual Property Cases

Patent - Abbreviated New Drug Application Cases, Dockets and Filings
Cases filed
Cases 151 - 160 of 1,187
Biogen Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00732
Plaintiff: Biogen Inc., Biogen Swiss Manufacturing GmbH and Alkermes Pharma Ireland Limited
Defendant: Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals Ltd et al v. Apotex Inc. et al
as 1:2023cv00734
Plaintiff: Actelion Pharmaceuticals Ltd and Actelion Pharmaceuticals US, Inc.
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Anobri Pharmaceuticals US, LLC et al
as 1:2023cv00715
Plaintiff: Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Defendant: Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd., Shaghai Anovent Pharmaceutical Co., Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Intercept Pharmaceuticals, Inc. et al v. Zenara Pharma Private Limited
as 1:2023cv00714
Plaintiff: Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe Limited
Defendant: Zenara Pharma Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Sun Pharmaceutical Industries Limited et al
as 1:2023cv00718
Plaintiff: Pfizer Inc., C.P. Pharmaceuticals International C.V., PF Prism C.V. and others
Defendant: Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. v. Apotex Inc. et al
as 1:2023cv00710
Plaintiff: Otsuka Pharmaceutical Co., Ltd.
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Anobri Pharmaceuticals US, LLC et al
as 1:2023cv00716
Plaintiff: Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH
Defendant: Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd. and Shanghai Anovent Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Aurobindo Pharma Limited et al
as 1:2023cv00717
Plaintiff: Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V. and others
Defendant: Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Galderma Laboratories, L.P. et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2023cv00711
Plaintiff: Galderma Laboratories, L.P. and TCD Royalty Sub LP
Defendant: Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Apotex Inc. v. Boehringer lngelheim Pharmaceuticals, Inc. et al
as 1:2023cv00704
Plaintiff: Apotex Inc.
Defendant: Boehringer lngelheim Pharmaceuticals, Inc., Boehringer lngelheim International GMBH, Boehringer lngelheim Corporation and others
Cause Of Action: 35 U.S.C. § 1 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?